Advertisement

Topics

Cell Cycle-Blocking Drugs Ibrance and Kisqali can Shrink Cancers by Enlisting Immune System in Attack on Cancer

20:01 EDT 22 Aug 2017 | Cancer Connect

In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, […]

The post Cell Cycle-Blocking Drugs Ibrance and Kisqali can Shrink Cancers by Enlisting Immune System in Attack on Cancer appeared first on .

Original Article: Cell Cycle-Blocking Drugs Ibrance and Kisqali can Shrink Cancers by Enlisting Immune System in Attack on Cancer

NEXT ARTICLE

More From BioPortfolio on "Cell Cycle-Blocking Drugs Ibrance and Kisqali can Shrink Cancers by Enlisting Immune System in Attack on Cancer"

Advertisement
Quick Search
Advertisement
Advertisement